{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:51:41Z","timestamp":1790301101740,"version":"4.1.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006244","name":"Stichting Kinderen Kankervrij","doi-asserted-by":"publisher","award":["297"],"award-info":[{"award-number":["297"]}],"id":[{"id":"10.13039\/501100006244","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Survivors of pediatric head and neck rhabdomyosarcoma (HNRMS) are at risk of developing endocrinopathies following local treatment, resulting from radiation damage to the pituitary gland, hypothalamus, or thyroid gland, often at a young age. Our aim was to determine the prevalence of endocrine dysfunction in long-term HNRMS survivors and compare the prevalence of anterior pituitary insufficiency (API) among different local treatment strategies: external beam radiation with photons, external beam radiation with protons, microscopically radical surgery combined with external irradiation, and macroscopic radical surgery combined with brachytherapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design and methods<\/jats:title>\n                  <jats:p>Head and neck rhabdomyosarcoma survivors treated between 1993 and 2017, with \u22652 years of follow-up, without recurrent disease or secondary malignancy were eligible for this study. The presence of any endocrine dysfunction was assessed cross-sectionally using Common Terminology Criteria of Adverse Events grading, anthropometrics, and biochemical testing. Retrospective chart review was added to this clinical assessment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Ninety-six survivors with long follow-up time (median, 9 years) were included. Any endocrinopathy was present in 35% of survivors, with 88% having pituitary, 6% peripheral (thyroid), and 6% combined insufficiencies. None had gonadal insufficiency. Growth hormone deficiency was diagnosed in 31 (32%) survivors, with additional pituitary insufficiencies in 12 (39%). In 8%, central precocious puberty preceded API. None of the survivors given brachytherapy had API.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The prevalence of pituitary dysfunction in HNRMS survivors is high, emphasizing the importance of systematic endocrine assessment during follow-up, including pubertal development and growth. Efforts should be made to further reduce extraneous irradiation to endocrine organs to prevent dysfunction later in life.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ejendo\/lvae168","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T10:51:56Z","timestamp":1736333516000},"page":"25-33","source":"Crossref","is-referenced-by-count":3,"title":["Endocrine dysfunction in long-term survivors of pediatric head and neck rhabdomyosarcoma"],"prefix":"10.1093","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6559-650X","authenticated-orcid":false,"given":"Michele","family":"Morfouace","sequence":"first","affiliation":[{"name":"Department of Pediatric Oncology, Princess M\u00e1xima Center for Pediatric Oncology , 3584 CS Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reineke A","family":"Schoot","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Princess M\u00e1xima Center for Pediatric Oncology , 3584 CS Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinka L F","family":"Hol","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Princess M\u00e1xima Center for Pediatric Oncology , 3584 CS Utrecht ,","place":["The Netherlands"]},{"name":"Department of Otorhinolaryngology, University Medical Center Utrecht , 3584 CX Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Minard-Colin","sequence":"additional","affiliation":[{"name":"Department of Pediatric and Adolescent Oncology, Gustave Roussy , 94805 Villejuif ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Kolb","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Gustave Roussy , 94805 Villejuif ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Boll\u00e9","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Gustave Roussy , 94805 Villejuif ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matumba T","family":"Kayembe","sequence":"additional","affiliation":[{"name":"Department of Biometrics, The Netherlands Cancer Institute , 1066 CX Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark N","family":"Gaze","sequence":"additional","affiliation":[{"name":"Department of Oncology, University College London Hospitals NHS Foundation Trust , NW1 2PB London ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0083-9370","authenticated-orcid":false,"given":"Eric","family":"Sandler","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Nemours Children's Health , Jacksonville, FL 32207 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutger R G","family":"Knops","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Princess M\u00e1xima Center for Pediatric Oncology , 3584 CS Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes H M","family":"Merks","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Princess M\u00e1xima Center for Pediatric Oncology , 3584 CS Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig E","family":"Smeele","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Princess M\u00e1xima Center for Pediatric Oncology , 3584 CS Utrecht ,","place":["The Netherlands"]},{"name":"Department of Oral and Maxillofacial Surgery, Amsterdam University Medical Centers , 1105 AZ Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J","family":"Indelicato","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Florida , Jacksonville, FL 32209 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Slater","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Great Ormond Street Hospital for Children NHS Foundation Trust , WC1N 3BH London ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanneke M","family":"van Santen","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Princess M\u00e1xima Center for Pediatric Oncology , 3584 CS Utrecht ,","place":["The Netherlands"]},{"name":"Department of Pediatric Endocrinology, Wilhelmina Childrens\u2019 Hospital , 3584 EA Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"issue":"1","key":"2025012806455377000_lvae168-B1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1470-2045(13)70548-5","article-title":"Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5-a population-based study","volume":"15","author":"Gatta","year":"2014","journal-title":"Lancet Oncol"},{"issue":"4","key":"2025012806455377000_lvae168-B2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ctrv.2010.02.003","article-title":"Epidemiology of childhood cancer","volume":"36","author":"Kaatsch","year":"2010","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"2025012806455377000_lvae168-B3","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1136\/adc.84.5.436","article-title":"Growth hormone and segmental growth in survivors of head and neck embryonal rhabdomyosarcoma","volume":"84","author":"Katz","year":"2001","journal-title":"Arch Dis Child"},{"key":"2025012806455377000_lvae168-B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2015.10.064","article-title":"Endocrine disorders among long-term survivors of childhood head and neck rhabdomyosarcoma","volume":"54","author":"Clement","year":"2016","journal-title":"Eur J Cancer"},{"issue":"7","key":"2025012806455377000_lvae168-B5","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/pbc.20310","article-title":"Long-term medical effects of childhood and adolescent rhabdomyosarcoma: a report from the childhood cancer survivor study","volume":"44","author":"Punyko","year":"2005","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"2025012806455377000_lvae168-B6","doi-asserted-by":"publisher","first-page":"6101","DOI":"10.1210\/jc.2019-00834","article-title":"Hypothalamic-pituitary disorders in childhood cancer survivors: prevalence, risk factors and long-term health outcomes","volume":"104","author":"van Iersel","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025012806455377000_lvae168-B7","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1200\/JCO.2014.56.7933","article-title":"Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: a report from the St Jude lifetime cohort study","volume":"33","author":"Chemaitilly","year":"2015","journal-title":"J Clin Oncol"},{"issue":"4","key":"2025012806455377000_lvae168-B8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/jnci\/djx224","article-title":"Chronic health conditions and neurocognitive function in aging survivors of childhood cancer: a report from the childhood cancer survivor study","volume":"110","author":"Cheung","year":"2018","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"2025012806455377000_lvae168-B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/pbc.28723","article-title":"Clinical impact of hypothalamic-pituitary disorders after conformal radiation therapy for pediatric low-grade glioma or ependymoma","volume":"67","author":"van Iersel","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"2025012806455377000_lvae168-B10","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1097\/01.HP.0000326342.47348.06","article-title":"Dose to normal tissues outside the radiation therapy patient's treated volume: a review of different radiation therapy techniques","volume":"95","author":"Purdy","year":"2008","journal-title":"Health Phys."},{"issue":"2","key":"2025012806455377000_lvae168-B11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00066-021-01867-1","article-title":"The value of brachytherapy in the age of advanced external beam radiotherapy: a review of the literature in terms of dosimetry","volume":"198","author":"Major","year":"2022","journal-title":"Strahlenther Onkol"},{"issue":"5","key":"2025012806455377000_lvae168-B12","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.ijrobp.2008.10.029","article-title":"The AMORE protocol for advanced-stage and recurrent nonorbital rhabdomyosarcoma in the head-and-neck region of children: a radiation oncology view","volume":"74","author":"Blank","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"2025012806455377000_lvae168-B13","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1200\/JCO.2005.08.130","article-title":"Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology-SIOP malignant mesenchymal tumor 89","volume":"23","author":"Stevens","year":"2005","journal-title":"J Clin Oncol"},{"issue":"20","key":"2025012806455377000_lvae168-B14","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1200\/JCO.2011.40.3287","article-title":"Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatric Oncology MMT95 study","volume":"30","author":"Oberlin","year":"2012","journal-title":"J Clin Oncol"},{"issue":"8","key":"2025012806455377000_lvae168-B15","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/S1470-2045(18)30337-1","article-title":"Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial","volume":"19","author":"Bisogno","year":"2018","journal-title":"Lancet Oncol"},{"issue":"11","key":"2025012806455377000_lvae168-B16","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/S1470-2045(19)30617-5","article-title":"Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial","volume":"20","author":"Bisogno","year":"2019","journal-title":"Lancet Oncol"},{"issue":"9","key":"2025012806455377000_lvae168-B17","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1200\/JCO.2007.15.0466","article-title":"Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults","volume":"27","author":"Dantonello","year":"2009","journal-title":"J Clin Oncol"},{"issue":"12","key":"2025012806455377000_lvae168-B18","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1200\/JCO.2001.19.12.3091","article-title":"Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease","volume":"19","author":"Crist","year":"2001","journal-title":"J Clin Oncol"},{"issue":"31","key":"2025012806455377000_lvae168-B19","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1200\/JCO.2014.55.6787","article-title":"Shorter-duration therapy using vincristine, dactinomycin, and lower-dose cyclophosphamide with or without radiotherapy for patients with newly diagnosed low-risk rhabdomyosarcoma: a report from the soft tissue sarcoma committee of the Children's oncology","volume":"32","author":"Walterhouse","year":"2014","journal-title":"J Clin Oncol"},{"issue":"27","key":"2025012806455377000_lvae168-B20","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1200\/JCO.2018.77.9694","article-title":"Addition of vincristine and irinotecan to vincristine, dactinomycin, and cyclophosphamide does not improve outcome for intermediate-risk rhabdomyosarcoma: a report from the children's oncology group","volume":"36","author":"Hawkins","year":"2018","journal-title":"J Clin Oncol"},{"issue":"1","key":"2025012806455377000_lvae168-B21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/pbc.24679","article-title":"The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the childhood cancer survivor study","volume":"61","author":"Green","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"2025012806455377000_lvae168-B22","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/S0959-8049(03)00363-0","article-title":"A novel local treatment strategy for advanced stage head and neck rhabdomyosarcomas in children: results of the AMORE protocol","volume":"39","author":"Buwalda","year":"2003","journal-title":"Eur J Cancer"},{"issue":"6","key":"2025012806455377000_lvae168-B23","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/pbc.24374","article-title":"Impact of extensive surgery in multidisciplinary approach of pterygopalatine\/infratemporal fossa soft tissue sarcoma","volume":"60","author":"Minard-Colin","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"2025012806455377000_lvae168-B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fped.2021.783754","article-title":"Locoregional control and survival in children, adolescents, and young adults with localized head and neck alveolar rhabdomyosarcoma\u2014the French experience","volume":"9","author":"Machavoine","year":"2022","journal-title":"Front Pediatr"},{"key":"2025012806455377000_lvae168-B25","author":"NCI common terminology criteria for adverse events (CTCAE)","year":"2009"},{"issue":"2","key":"2025012806455377000_lvae168-B26","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1136\/archdischild-2011-301095","article-title":"A simple calculation of the target height","volume":"97","author":"Van Dommelen","year":"2012","journal-title":"Arch Dis Child"},{"issue":"3","key":"2025012806455377000_lvae168-B27","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1136\/adc.2007.120188","article-title":"Developing evidence-based guidelines for referral for short stature","volume":"93","author":"Grote","year":"2008","journal-title":"Arch Dis Child"},{"issue":"11","key":"2025012806455377000_lvae168-B28","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1210\/jcem.85.11.6984","article-title":"Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH research society","volume":"85","author":"Attie","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025012806455377000_lvae168-B29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1542\/peds.109.1.45","article-title":"Centers for disease control and prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version","volume":"109","author":"Ogden","year":"2002","journal-title":"Pediatrics"},{"issue":"6","key":"2025012806455377000_lvae168-B30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nrendo.2016.45","article-title":"Late endocrine effects of childhood cancer","volume":"12","author":"Rose","year":"2016","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"2025012806455377000_lvae168-B31","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/pbc.20327","article-title":"ACTH deficiency in childhood cancer survivors","volume":"45","author":"Rose","year":"2005","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"2025012806455377000_lvae168-B32","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1210\/endrev\/bnab040","article-title":"Hypothalamic-pituitary and other endocrine surveillance among childhood cancer survivors","volume":"43","author":"van Iersel","year":"2022","journal-title":"Endocr Rev"},{"issue":"4","key":"2025012806455377000_lvae168-B33","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s004310050599","article-title":"Final height and puberty in 40 patients after antileukaemic treatment during childhood","volume":"156","author":"Mohnike","year":"1997","journal-title":"Eur J Pediatr"},{"issue":"6","key":"2025012806455377000_lvae168-B34","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1203\/00006450-199306000-00008","article-title":"Long-term effects of treatment for acute lymphoblastic leukemia with and without cranial irradiation on growth and puberty: a comparative study","volume":"33","author":"Hokken-Koelega","year":"1993","journal-title":"Pediatr Res"},{"issue":"12","key":"2025012806455377000_lvae168-B35","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1530\/EC-18-0311","article-title":"Declining free thyroxine levels over time in irradiated childhood brain tumor survivors","volume":"7","author":"van Iersel","year":"2018","journal-title":"Endocr Connect"},{"issue":"11","key":"2025012806455377000_lvae168-B36","doi-asserted-by":"publisher","first-page":"4998","DOI":"10.1210\/jc.2019-00539","article-title":"Clinical importance of free thyroxine concentration decline after radiotherapy for pediatric and adolescent brain tumors","volume":"104","author":"Van Iersel","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025012806455377000_lvae168-B37","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/pbc.21316","article-title":"Timing of menarche among survivors of childhood acute lymphoblastic leukemia: a report from the childhood cancer survivor study","volume":"50","author":"Chow","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"2025012806455377000_lvae168-B38","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/cen.12964","article-title":"Central precocious puberty following the diagnosis and treatment of paediatric cancer and central nervous system tumours: presentation and long-term outcomes","volume":"84","author":"Chemaitilly","year":"2016","journal-title":"Clin Endocrinol"},{"issue":"2","key":"2025012806455377000_lvae168-B39","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/S1470-2045(20)30594-5","article-title":"Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"22","author":"Mulder","year":"2021","journal-title":"Lancet Oncol"},{"issue":"28","key":"2025012806455377000_lvae168-B40","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1200\/JCO.2015.64.3288","article-title":"Recommendations for premature ovarian insufficiency surveillance for female survivors of childhood, adolescent, and young adult cancer: a report from the international late effects of childhood cancer guideline harmonization group in collaboration with the PanCareSurFup consortium","volume":"34","author":"van Dorp","year":"2016","journal-title":"J Clin Oncol"},{"issue":"2","key":"2025012806455377000_lvae168-B41","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000495943","article-title":"Hypogonadism in children with a previous history of cancer: endocrine management and follow-up","volume":"91","author":"van Santen","year":"2019","journal-title":"Horm Res Paediatr"},{"issue":"18","key":"2025012806455377000_lvae168-B42","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1002\/cncr.32204","article-title":"Increased local failure for patients with intermediate-risk rhabdomyosarcoma on ARST0531: a report from the Children\u2019s Oncology Group","volume":"125","author":"Casey","year":"2019","journal-title":"Cancer"},{"key":"2025012806455377000_lvae168-B43","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ejca.2021.04.007","article-title":"Non-parameningeal head and neck rhabdomyosarcoma in children, adolescents, and young adults: experience of the European paediatric soft tissue sarcoma Study Group (EpSSG)\u2014RMS2005 study","volume":"151","author":"Glosli","year":"2021","journal-title":"Eur J Cancer"},{"issue":"9","key":"2025012806455377000_lvae168-B44","doi-asserted-by":"publisher","first-page":"e0274274","DOI":"10.1371\/journal.pone.0274274","article-title":"Pre- and postdiagnosis growth failure, adult short stature, and untreated growth hormone deficiency in radiotherapy-treated long-term survivors of childhood brain tumor","volume":"17","author":"Anttonen","year":"2022","journal-title":"PLoS One"},{"issue":"5","key":"2025012806455377000_lvae168-B45","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1159\/000495760","article-title":"The predictive value of insulin-like growth factor 1 in irradiation-dependent growth hormone deficiency in childhood cancer survivors","volume":"90","author":"Cattoni","year":"2019","journal-title":"Horm Res Paediatr"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/192\/1\/25\/61373542\/lvae168.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/192\/1\/25\/61373542\/lvae168.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T06:46:05Z","timestamp":1738046765000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/192\/1\/25\/7945402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvae168","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2025,1]]}}}